BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6441993)

  • 1. [Metabolic radiotherapy in differentiated carcinoma of the thyroid].
    Serena A; Richter JA; Charvet MA; Honorato J
    Rev Med Univ Navarra; 1984 Dec; 28(4):35-9. PubMed ID: 6441993
    [No Abstract]   [Full Text] [Related]  

  • 2. [Radiometabolic therapy in differentiated carcinoma of the thyroid gland].
    Casara D
    Chir Ital; 1994; 46(4):53-5. PubMed ID: 7882444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolic therapy with radioiodine of differentiated thyroid tumor].
    Bestagno M; Campagnari G
    Minerva Med; 1986 Nov; 77(44):2113-6. PubMed ID: 3785727
    [No Abstract]   [Full Text] [Related]  

  • 4. Why should the radioiodine dose be different in patients with differentiated thyroid carcinoma prepared with recombinant human TSH?
    Pitoia F; Degrossi OJ; Niepomniszcze H
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):924; author reply 924-5. PubMed ID: 15034676
    [No Abstract]   [Full Text] [Related]  

  • 5. 131I dosimetry and thyroid stunning.
    Gerard SK; Park HM
    J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we read carefully?
    Medvedec M
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):475-6. PubMed ID: 12634977
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of recombinant human TSH aided radioiodine doses administered in patients with differentiated thyroid carcinoma.
    Pitoia F; Tamer EE; Schere DB; Passerieu M; Bruno OD; Niepomniszcze H
    Medicina (B Aires); 2006; 66(2):125-30. PubMed ID: 16715760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of medullary carcinoma of the thyroid with I-131.
    Nusynowitz ML; Pollard E; Benedetto AR; Lecklitner ML; Ware RW
    J Nucl Med; 1982 Feb; 23(2):143-6. PubMed ID: 7057256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The external radiotherapy of differentiated thyroid carcinoma].
    Sautter-Bihl ML; Heinze HG
    Dtsch Med Wochenschr; 1992 Apr; 117(17):665-8. PubMed ID: 1369745
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insular carcinoma of the thyroid. Apropos of a case and review of the literature].
    Auge B; Rodier JF; Pusel J; Janser JC
    Arch Anat Cytol Pathol; 1993; 41(3-4):124-8. PubMed ID: 8279853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
    Robbins RJ; Schlumberger MJ
    J Nucl Med; 2005 Jan; 46 Suppl 1():28S-37S. PubMed ID: 15653649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with differentiated thyroid carcinoma benefit from radioiodine remnant ablation.
    Haugen BR
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3665-7. PubMed ID: 15292284
    [No Abstract]   [Full Text] [Related]  

  • 14. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy in differentiated thyroid carcinoma.
    Salvatori M; Rufini V; Garganese MC; Di Giuda D
    Rays; 2000; 25(2):221-38. PubMed ID: 11370540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell differentiation and iodine-131 uptake in poorly differentiated thyroid tumour in response to nevirapine.
    Landriscina M; Modoni S; Fabiano A; Fersini A; Barone C; Ambrosi A; Cignarelli M
    Lancet Oncol; 2006 Oct; 7(10):877-9. PubMed ID: 17012051
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid stunning in clinical practice: is it a real problem?
    Filesi M; Colandrea M; Montesano T; D'Apollo R; Ronga G
    Minerva Endocrinol; 2009 Mar; 34(1):29-36. PubMed ID: 19209126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant treatment of thyroid cancer.
    Beauduin M; Hermans J; Majois F
    Acta Otorhinolaryngol Belg; 1987; 41(5):944-5. PubMed ID: 3454107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.